Blagg Christopher R
Northwest Kidney Centers, University of Washington, Seattle, Washington, USA.
Nephrology (Carlton). 2005 Jun;10(3):206-14. doi: 10.1111/j.1440-1797.2005.00383.x.
Home haemodialysis was first developed 40 years ago as a means of treating more patients with the limited funds then available. It soon became obvious that the treatment worked well and subsequent studies and experience have confirmed that it improves both mortality and morbidity and provides the best quality of life and other benefits for dialysis patients. The present review describes the history of the development of home haemodialysis in Seattle and elsewhere and the lessons learned about its benefits in the early days, which are just as relevant today. The advantages and disadvantages are discussed, as are the issues of which patients are candidates for this treatment and what is required of a home haemodialysis training and support programme. The decline in use of home haemodialysis in the USA and elsewhere is described and the actions that may already be beginning to reverse this trend. The role of home haemodialysis in giving the opportunity for longer hours of dialysis three times a week or on alternate nights is important. There is discussion of the relationship of home haemodialysis and peritoneal dialysis and its important future role as the means to enable treatment with more frequent short daily and long nightly haemodialysis.
家庭血液透析最早于40年前开发出来,作为一种利用当时有限资金治疗更多患者的手段。很快就发现这种治疗效果良好,随后的研究和经验证实,它既能提高生存率又能降低发病率,为透析患者提供了最佳生活质量和其他益处。本综述描述了西雅图及其他地区家庭血液透析的发展历程,以及早期所了解到的其益处,这些益处如今依然具有相关性。文中讨论了家庭血液透析的优缺点,以及哪些患者适合这种治疗、家庭血液透析培训与支持项目的要求等问题。还描述了美国及其他地区家庭血液透析使用量的下降情况,以及可能已经开始扭转这一趋势的行动。家庭血液透析在提供每周三次或隔天夜间进行更长时间透析机会方面的作用很重要。文中讨论了家庭血液透析与腹膜透析的关系,以及它作为实现更频繁的短日和长夜间血液透析治疗手段的重要未来作用。